Confo Therapeutics: Funding, Investors & Team (Sep 2026)
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical needs that have not been met. The company uses its unique CONFO® technology to stabilize the functional shapes of GPCRs, providing a strong foundation for drug discovery. By stabilizing the active state conformations of these receptors, Confo Therapeutics is able to uncover important structural details that were previously unknown, leading to the development of new agonists for improved therapeutic treatments.
Confo Therapeutics has raised $69.8M across 4 funding rounds on record, the most recent an undisclosed round of $1.2M announced in Oct 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Confo Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Confo Therapeutics Funding Rounds
Confo Therapeutics raised $1.8M in a Grant announced in Jun 2022.
1.8 years later, an undisclosed round of $1.7M was announced in Mar 2024.
4 months later, a Series B of $65.1M was announced in Jul 2024.
1.3 years later, an undisclosed round of $1.2M was announced in Oct 2025.
Confo Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Confo Therapeutics Funding Compared to Other Biotechnology Startups
Confo Therapeutics' latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Confo Therapeutics in Biotechnology and Brussels
Companies Similar to Confo Therapeutics
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells,…
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…
Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…
4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…
Tavira Therapeutics creates an innovative platform to improve the delivery of genes using AAV. By adding…
AgomAb is creating sub-atomic treatments for the recovery of harmed tissues. Their exceptional agonistic…
BioSourcing is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global…
Confo Therapeutics Funding FAQs
What does Confo Therapeutics do?
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical needs that have not been met. The company uses its unique CONFO® technology to stabilize the functional shapes of GPCRs, providing a strong foundation for drug discovery. By stabilizing the active state conformations of these receptors, Confo Therapeutics is able to uncover important structural details that were previously unknown, leading to the development of new agonists for improved therapeutic treatments.
How much funding has Confo Therapeutics raised?
Confo Therapeutics has raised $69.8M across 4 rounds on record. The most recent is an undisclosed round of $1.2M announced in Oct 2025.
When did Confo Therapeutics last raise funding?
Confo Therapeutics' most recent funding round on record is an undisclosed round of $1.2M, announced in Oct 2025.
Who founded Confo Therapeutics?
FundedIQ lists Jan Steyaert (Founder), Toon Laeremans (Founder) at Confo Therapeutics.
Where is Confo Therapeutics headquartered?
Confo Therapeutics is based in Brussels, Brussels Hoofdstedelijk Gewest, Belgium.
How many employees does Confo Therapeutics have?
Confo Therapeutics is in the 51-100 employee band.
How does Confo Therapeutics' funding compare to other Biotechnology startups?
Confo Therapeutics' latest round of $1.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Confo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Confo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.